The Royal Marsden NHS Foundation Trust is rolling out a set of MSoft systems that will deliver ‘vein to vein’ electronic blood tracking for its hospitals in Chelsea and Sutton.
The trust has bought four of the company’s products – Bloodhound, Sample 360, PPID360 and Vital360 – and already has Bloodhound live.
Bloodhound controls access to and from blood fridges, and works with the PPID360 bedside management system that enables barcoded blood units to be matched with patient barcoded wristbands.
Sample360 is a phlebotomy sample tracking and management solution, while Vital360 enables trusts to use Bloodhound as an observations and decision support tool.
Matt McAlister, the managing director of MSoft, said: “Specialist cancer surgery has a higher level of blood usage, because processes such as cell salvage are not available, due to the risk of cross contamination.
“[The first patient to receive blood after Bloodhound went live] received an incredible 57 units of blood.”
MSoft was set up in 1999 and now works worldwide, as well as in more than 100 NHS and UK private hospitals. It is based in the Wirral, where it employs 30 people. The trust purchased Bloodhound through NHS Supply Chain.